Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M38,296Revenue (TTM) $M4,860Net Margin (%)18.1Altman Z-Score11.1
Enterprise Value $M37,736EPS (TTM) $7.6Operating Margin %27.4Piotroski F-Score5
P/E(ttm)47.5Beneish M-Score-2.8Pre-tax Margin (%)27.4Higher ROA y-yN
Price/Book8.610-y EBITDA Growth Rate %--Quick Ratio2.2Cash flow > EarningsY
Price/Sales8.65-y EBITDA Growth Rate %--Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow43.8y-y EBITDA Growth Rate %8.6ROA % (ttm)14.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)21.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M106ROIC % (ttm)25.9Gross Margin Increase y-yY

Gurus Latest Trades with REGN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

REGN is held by these investors:

REGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2017-01-11Buy87,298$369.71-2.35view
BAKER CHARLES ADirector 2016-12-12Sell3,000$392.02-7.91view
RYAN ARTHUR FDirector 2016-11-15Sell2,000$429.34-15.92view
GOLDSTEIN JOSEPH LDirector 2016-11-14Sell2,125$450-19.78view
GOLDSTEIN JOSEPH LDirector 2016-07-29Sell2,125$425-15.06view
Sanofi10% Owner 2016-06-14Buy64,731$363.86-0.78view
RYAN ARTHUR FDirector 2016-05-24Sell1,000$396.64-8.98view
Van Plew Daniel PEVP & General Mgr Industrial O 2016-05-18Sell4,413$385.77-6.42view
GOLDSTEIN JOSEPH LDirector 2016-04-06Sell2,000$425-15.06view
GOLDSTEIN JOSEPH LDirector 2016-03-21Sell2,000$375-3.73view

Quarterly/Annual Reports about REGN:

News about REGN:

Articles On GuruFocus.com
Manning & Napier’s Top 3 New Holdings Jan 26 2017 
A Green Light on Bayer Jan 19 2017 
Largest Insider Trades of the Week Jan 16 2017 
Take a Look at Sanofi Oct 05 2016 
3 of Frank Sands' Top 5 Transactions in 2nd Quarter Were Reductions Aug 14 2016 
Edward Owens Top 2nd Quarter Investments Aug 03 2016 
Frank Sands Sells Visa, Baidu, Alibaba May 24 2016 
Baron Funds Comments on Regeneron Pharmaceuticals May 23 2016 
Market-Beating Vanguard Health Care Fund Adds Shares to 5 Positions May 03 2016 
Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 

More From Other Websites
Regeneron Pharma downgraded by Goldman Feb 16 2017
Biotech Stock Roundup: Regeneron's Praluent to Remain on Market for Now, GILD Presents HIV Data Feb 15 2017
ETFs with exposure to Regeneron Pharmaceuticals, Inc. : February 14, 2017 Feb 14 2017
Regeneron Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : REGN-US :... Feb 14 2017
Regeneron: It's All Riding On Dupixent Feb 13 2017
Regeneron Pharmaceuticals, Inc. :REGN-US: Earnings Analysis: 2016 By the Numbers : February 13, 2017 Feb 13 2017
Regeneron Announces Upcoming 2017 Investor Conference Presentations Feb 13 2017
Regeneron Pharmaceuticals, Inc. :REGN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 10,... Feb 10 2017
Blog Coverage Acorda's Stock Price Soared Above 20% on Positive Data from Parkinson Disease Late... Feb 10 2017
[$$] 12 Stocks to Benefit Most From the House Tax Plan Feb 10 2017
Edited Transcript of REGN earnings conference call or presentation 9-Feb-17 1:30pm GMT Feb 09 2017
Regeneron Defies Light Q4 Sales, Eylea Outlook On Amgen-Rivaling LDL Win Feb 09 2017
Regeneron says it is being investigated by the US Attorney's Office over patient assistance... Feb 09 2017
Regeneron: Whiplash! Feb 09 2017
[$$] Regeneron Is Primed for a Second Act Feb 09 2017
Regeneron Pharmaceuticals Inc (REGN) and Sanofi SA (ADR) (SNY) Obtain Suspension of Injunction for... Feb 09 2017
Regeneron (REGN) Misses on Q4 Earnings & Sales, View Bleak Feb 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)